Manual review processes
Email-driven reviews create fragmented documentation and inconsistent approval processes.
ERMA Evaluate™ validates promotional materials against current FDA and OPDP guidance, flags compliance risk before submission, and automates Form 2253 preparation — so every asset is built to clear regulatory review.
Pharma compliance software helps organizations manage regulatory requirements, document decisions, maintain audit trails, and ensure content aligns with applicable FDA regulations and industry standards.
Regulatory agencies continue to increase scrutiny of pharmaceutical communications. Even minor compliance issues can create significant operational and commercial consequences.
Email-driven reviews create fragmented documentation and inconsistent approval processes.
Digital channels have dramatically increased the amount of content requiring review.
FDA guidance, enforcement actions, and industry standards continue to evolve.
Teams often lack real-time insight into review status, bottlenecks, and risk areas.
Artificial intelligence is transforming how pharmaceutical companies manage compliance — enabling teams to focus on strategic decision-making rather than administrative tasks.
Prioritize solutions that combine regulatory rigor with the speed modern teams need.
Pharma compliance software helps life-sciences teams ensure promotional and regulatory materials meet FDA requirements — validating content against current guidance, managing review, and preparing submission-ready documentation.
OPDP is the FDA's Office of Prescription Drug Promotion, which regulates prescription drug advertising. OPDP compliance means promotional materials meet its standards for fair balance, substantiation, and disclosure.
AI detects promotional claims automatically, matches them to supporting references, identifies missing substantiation, monitors FDA guidance updates, and surfaces potential risks before approval — freeing teams for strategic decisions.
No. The most successful life sciences organizations leverage compliance technology to accelerate approvals while maintaining regulatory confidence — reducing review timelines and strengthening audit readiness.
Real solutions for real MLR challenges